​

Elanco Animal Health (ELAN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ELAN Stock Forecast

Elanco Animal Health (ELAN) stock forecast, based on 14 Wall Street analysts, predicts a 12-month average price target of $14.67, with a high of $18.00 and a low of $12.00. This represents a 73.82% increase from the last price of $8.44.

$8 $10 $12 $14 $16 $18 High: $18 Avg: $14.67 Low: $12 Last Closed Price: $8.44

ELAN Stock Rating

Elanco Animal Health stock's rating consensus is Buy, based on 14 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (64.29%), 4 Hold (28.57%), 1 Sell (7.14%), and 0 Strong Sell (0.00%).

Buy
Total 14 0 1 4 9 Strong Sell Sell Hold Buy Strong Buy

ELAN Price Target Upside V Benchmarks

TypeNameUpside
StockElanco Animal Health73.82%
SectorHealthcare Stocks 35.94%
IndustrySpecialty & Generic Drug Manufacturers Stocks45.40%

Price Target Trends

1M3M12M
# Anlaysts-16
Avg Price Target-$12.00$16.83
Last Closing Price$8.44$8.44$8.44
Upside/Downside-42.18%99.41%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25267--15
Mar, 25367--16
Feb, 25268--16
Jan, 25268--16
Dec, 24368--17
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 06, 2025Piper Sandler$12.00$10.8310.80%42.18%
Dec 09, 2024Andrea AlfonsoUBS$18.00$12.5044.00%113.27%
Dec 02, 2024Daniel ClarkLeerink Partners$14.00$13.166.38%65.88%
Sep 23, 2024Balaji PrasadBarclays$22.00$14.0756.36%160.66%
Jul 01, 2024David WestenbergPiper Sandler$16.00$14.4310.88%89.57%
May 13, 2024David WestenbergPiper Sandler$19.00$17.0011.76%125.12%
Mar 12, 2024David WestenbergPiper Sandler$18.00$15.7714.14%113.27%
Jan 05, 2024Jonathan BlockStifel Nicolaus$20.00$15.4529.45%136.97%
Sep 12, 2022Barclays$18.00$15.0020.00%113.27%
Aug 16, 2022David WestenbergPiper Sandler$21.00$19.0810.06%148.82%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 09, 2024UBSBuyinitialise
Dec 02, 2024Leerink PartnersMarket Performinitialise
Oct 28, 2024Morgan StanleyBuyBuyhold
Sep 23, 2024BarclaysOverweightOverweighthold
Sep 20, 2024Piper SandlerNeutralNeutralhold
Sep 19, 2024Morgan StanleyUnderperformUnderperformhold
Sep 19, 2024Morgan StanleyOverweightEqual-Weightdowngrade
Jul 01, 2024Piper SandlerNeutralNeutralhold
May 13, 2024Piper SandlerNeutralNeutralhold
May 09, 2024Bank of America SecuritiesBuyBuyhold

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 $3 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.27$-0.97$-0.15$-2.50$0.68----
Avg Forecast$0.45$1.01$1.04$0.92$0.91$0.90$1.05$1.22$1.44
High Forecast$0.46$1.02$1.06$0.95$0.92$0.99$2.32$1.49$1.47
Low Forecast$0.44$0.99$1.03$0.91$0.90$0.82$0.28$0.86$1.42
Surprise %-382.22%-196.04%-114.42%-371.74%-25.27%----

Revenue Forecast

$3B $4B $4B $5B $5B $6B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$3.27B$4.76B$4.42B$4.42B$4.44B----
Avg Forecast$3.19B$4.75B$4.41B$4.39B$4.42B$4.54B$4.75B$5.03B$5.28B
High Forecast$3.21B$4.79B$4.45B$4.40B$4.44B$4.57B$4.75B$5.04B$5.36B
Low Forecast$3.15B$4.70B$4.38B$4.38B$4.34B$4.49B$4.75B$5.01B$5.23B
Surprise %2.66%0.21%0.19%0.72%0.35%----

Net Income Forecast

$-2B $-1B $-600M $100M $800M $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-560.10M$-472.00M$-74.00M$-1.23B$338.00M----
Avg Forecast$-432.65M$-378.78M$-141.47M$-1.23B$450.17M$445.93M$639.60M$578.20M$710.55M
High Forecast$-346.12M$-303.02M$-94.52M$-822.50M$455.07M$487.35M$1.14B$732.39M$722.92M
Low Forecast$-519.18M$-454.53M$-188.41M$-1.64B$445.28M$404.50M$137.76M$424.01M$700.70M
Surprise %29.46%24.61%-47.69%--24.92%----

ELAN Forecast FAQ

Is Elanco Animal Health stock a buy?

Elanco Animal Health stock has a consensus rating of Buy, based on 14 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 9 Buy, 4 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Elanco Animal Health is a favorable investment for most analysts.

What is Elanco Animal Health's price target?

Elanco Animal Health's price target, set by 14 Wall Street analysts, averages $14.67 over the next 12 months. The price target range spans from $12 at the low end to $18 at the high end, suggesting a potential 73.82% change from the previous closing price of $8.44.

How does Elanco Animal Health stock forecast compare to its benchmarks?

Elanco Animal Health's stock forecast shows a 73.82% upside, outperforming the average forecast for the healthcare stocks sector (35.94%) and outperforming the specialty & generic drug manufacturers stocks industry (45.40%).

What is the breakdown of analyst ratings for Elanco Animal Health over the past three months?

  • April 2025: 13.33% Strong Buy, 40.00% Buy, 46.67% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 18.75% Strong Buy, 37.50% Buy, 43.75% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 12.50% Strong Buy, 37.50% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.

What is Elanco Animal Health’s EPS forecast?

Elanco Animal Health's average annual EPS forecast for its fiscal year ending in December 2025 is $0.9, marking a 32.35% increase from the reported $0.68 in 2024. Estimates for the following years are $1.05 in 2026, $1.22 in 2027, and $1.44 in 2028.

What is Elanco Animal Health’s revenue forecast?

Elanco Animal Health's average annual revenue forecast for its fiscal year ending in December 2025 is $4.54B, reflecting a 2.31% increase from the reported $4.44B in 2024. The forecast for 2026 is $4.75B, followed by $5.03B for 2027, and $5.28B for 2028.

What is Elanco Animal Health’s net income forecast?

Elanco Animal Health's net income forecast for the fiscal year ending in December 2025 stands at $445.93M, representing an 31.93% increase from the reported $338M in 2024. Projections indicate $639.6M in 2026, $578.2M in 2027, and $710.55M in 2028.